In this interview, Klick Health’s Jasmine Singh sits down with Dr. Rahul Banerjee from Fred Hutchinson Cancer Institute to discuss the concept of “Time Toxicity” in cancer care. They explore how the extensive hours patients spend attending medical appointments, undergoing tests, and managing medications impact treatment decisions, quality of life, and patient outcomes. Dr. Banerjee also highlights how clinical practice and industry standards can evolve to better prioritize patient-centered care.

Rahul Banerjee

Jasmine Singh

Understanding the Unspoken Burden of Time Toxicity

Review how Asembia 2025 spotlighted AI, policy shifts, and how pharmacists will reshape specialty pharmacy with smarter, patient-centered access strategies.

Jodie Grubb

Liam Stegman

Redefining Access, Innovation, and Impact in Specialty Pharmacy: Insights from Asembia 2025

Google’s cookie deprecation pause is reshaping pharma media strategy. This POV explains what it means now and how to stay prepared for what’s next.

Kristy Quagliariello

A Quiet Collapse of a Cookieless Future

Part of Klick’s Difference-Making Strategy series, explore how PR, influence, and strategy evolve when brands focus on earning attention, not just buying it.

Brian Kaiser

Amanda Kleinberg

Jessica Botting

Rethinking PR, Influence, and Strategy in the Age of Earned Experience

This POV breaks down new deliverability rules from ISPs and shares how marketers can protect inbox placement while building trust and improving performance.

Daeyoung Kang

Claire Howard

Deliverability is an Evergreen Strategy

It’s time to consider how the hidden burden of time toxicity shapes cancer care. Explore why addressing it can unlock better outcomes, equity, and a positive brand experience.


Dane Lund

Jorge Durand

Emerging Trends: Time Toxicity in Oncology

Oncology engagement is evolving. Learn how AI, real-world data, and digital behaviors are reshaping how we connect with time-pressed HCPs in a fast-moving field.

JJ Mifsud

Brad Aufderheide

Cutting Through the Noise: Oncology Engagement for the Digital Era

See how AI, telemedicine, and digital screening are transforming cancer care—and why true equity demands broadband access, trust, and systemic investment.

Amy Gómez

Health Tech and the Fight for Cancer Equity: Breaking Barriers in Cancer Care

AI and automation are transforming MLR review by improving efficiency, reducing rework, and enabling compliant content reuse. Discover how to unlock speed without sacrificing accuracy.

Descubrir

Stay Informed with the Klick Wire